Vimta Labs Limited (VIMTALABS.BO)
INR 1030.5
(0.92%)
INR 1030.5
(0.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 536.04 Million INR | -14.41% |
| 2022 | 616.95 Million INR | 11.51% |
| 2021 | 553.25 Million INR | 93.01% |
| 2020 | 286.64 Million INR | 296.95% |
| 2019 | 72.21 Million INR | -78.57% |
| 2018 | 336.91 Million INR | 23.73% |
| 2017 | 272.3 Million INR | 48.25% |
| 2016 | 183.68 Million INR | 111.39% |
| 2015 | 86.89 Million INR | -6.82% |
| 2014 | 93.25 Million INR | -49.5% |
| 2013 | 184.64 Million INR | 98.75% |
| 2012 | 92.9 Million INR | 184.83% |
| 2011 | -109.51 Million INR | -1420.21% |
| 2010 | -7.2 Million INR | -110.17% |
| 2009 | 70.86 Million INR | -17.23% |
| 2008 | 85.61 Million INR | -18.85% |
| 2007 | 105.49 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 163.09 Million INR | -0.11% |
| 2023 Q1 | 161.55 Million INR | 0.12% |
| 2023 Q3 | 131.46 Million INR | 88.66% |
| 2023 FY | 528.03 Million INR | -14.41% |
| 2023 Q2 | 69.68 Million INR | -56.87% |
| 2023 Q4 | 163.27 Million INR | 24.2% |
| 2022 FY | 616.95 Million INR | 11.51% |
| 2022 Q1 | 166.57 Million INR | 1.8% |
| 2022 Q3 | 136.08 Million INR | -23.54% |
| 2022 Q4 | 161.35 Million INR | 18.57% |
| 2022 Q2 | 177.98 Million INR | 6.85% |
| 2021 Q2 | 144.26 Million INR | 29.28% |
| 2021 Q4 | 163.62 Million INR | 9.0% |
| 2021 FY | 553.25 Million INR | 93.01% |
| 2021 Q1 | 111.59 Million INR | -30.13% |
| 2021 Q3 | 150.11 Million INR | 4.06% |
| 2020 Q3 | 112.12 Million INR | 9.78% |
| 2020 Q2 | 102.13 Million INR | 662.08% |
| 2020 FY | 286.64 Million INR | 296.95% |
| 2020 Q1 | -18.17 Million INR | -8159.09% |
| 2020 Q4 | 159.72 Million INR | 42.45% |
| 2019 Q2 | 14.45 Million INR | -35.58% |
| 2019 FY | 72.21 Million INR | -78.57% |
| 2019 Q1 | 22.43 Million INR | -84.84% |
| 2019 Q4 | -220 Thousand INR | -100.31% |
| 2019 Q3 | 70.54 Million INR | 388.17% |
| 2018 Q2 | 120.77 Million INR | 18.51% |
| 2018 Q1 | 101.91 Million INR | 13.07% |
| 2018 Q4 | 147.95 Million INR | 70.88% |
| 2018 FY | 336.91 Million INR | 23.73% |
| 2018 Q3 | 86.58 Million INR | -28.31% |
| 2017 Q2 | 89.72 Million INR | 205.27% |
| 2017 Q3 | 98.39 Million INR | 9.66% |
| 2017 FY | 272.3 Million INR | 48.25% |
| 2017 Q4 | 90.13 Million INR | -8.4% |
| 2017 Q1 | 29.39 Million INR | -34.06% |
| 2016 Q3 | 52.13 Million INR | 31.6% |
| 2016 Q2 | 39.61 Million INR | -20.59% |
| 2016 Q1 | 49.88 Million INR | 265.68% |
| 2016 Q4 | 44.57 Million INR | -14.52% |
| 2016 FY | 183.68 Million INR | 111.39% |
| 2015 Q4 | 13.64 Million INR | -43.25% |
| 2015 Q2 | 45.29 Million INR | 151.57% |
| 2015 Q1 | 18 Million INR | -50.31% |
| 2015 Q3 | 24.04 Million INR | -46.92% |
| 2015 FY | 86.89 Million INR | -6.82% |
| 2014 FY | 93.25 Million INR | -49.5% |
| 2014 Q4 | 36.22 Million INR | 230.77% |
| 2014 Q3 | 10.95 Million INR | -28.82% |
| 2014 Q2 | 15.38 Million INR | -49.85% |
| 2014 Q1 | 30.68 Million INR | 161.32% |
| 2013 Q4 | 11.74 Million INR | -78.23% |
| 2013 Q2 | 61.58 Million INR | 7.29% |
| 2013 Q1 | 57.39 Million INR | 26.68% |
| 2013 FY | 184.64 Million INR | 98.75% |
| 2013 Q3 | 53.92 Million INR | -12.43% |
| 2012 Q4 | 45.3 Million INR | 127.43% |
| 2012 FY | 92.9 Million INR | 184.83% |
| 2012 Q1 | 16.5 Million INR | 140.17% |
| 2012 Q3 | 19.92 Million INR | 78.45% |
| 2012 Q2 | 11.16 Million INR | -32.38% |
| 2011 Q3 | -31.43 Million INR | -46.12% |
| 2011 FY | -109.51 Million INR | -1420.21% |
| 2011 Q4 | -41.09 Million INR | -30.75% |
| 2011 Q2 | -21.5 Million INR | 0.0% |
| 2010 FY | -7.2 Million INR | -110.17% |
| 2009 FY | 70.86 Million INR | -17.23% |
| 2008 FY | 85.61 Million INR | -18.85% |
| 2007 FY | 105.49 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Krsnaa Diagnostics Limited | 696.99 Million INR | 23.091% |
| Dr. Lal PathLabs Limited | 4.76 Billion INR | 88.745% |
| Metropolis Healthcare Limited | 2.05 Billion INR | 73.92% |
| Thyrocare Technologies Limited | 917 Million INR | 41.543% |
| Vijaya Diagnostic Centre Limited | 3.62 Billion INR | 85.227% |